Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 127

    1.

    Tumor aromatase expression as a prognostic factor for local control in young breast cancer patients after breast-conserving treatment.

    Bollet MA, Savignoni A, De Koning L, Tran-Perennou C, Barbaroux C, Degeorges A, Sigal-Zafrani B, Almouzni G, Cottu P, Salmon R, Servant N, Fourquet A, de Cremoux P.

    Breast Cancer Res. 2009;11(4):R54. Epub 2009 Jul 28.

    PMID:
    19638208
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    2.

    Impact of locoregional treatment on the early-stage breast cancer patients: a retrospective analysis.

    van der Hage JA, Putter H, Bonnema J, Bartelink H, Therasse P, van de Velde CJ; EORTC Breast Cancer Group.

    Eur J Cancer. 2003 Oct;39(15):2192-9.

    PMID:
    14522378
    [PubMed - indexed for MEDLINE]
    3.

    Overview of resistance to systemic therapy in patients with breast cancer.

    Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN.

    Adv Exp Med Biol. 2007;608:1-22. Review.

    PMID:
    17993229
    [PubMed - indexed for MEDLINE]
    4.

    A candidate molecular signature associated with tamoxifen failure in primary breast cancer.

    Vendrell JA, Robertson KE, Ravel P, Bray SE, Bajard A, Purdie CA, Nguyen C, Hadad SM, Bieche I, Chabaud S, Bachelot T, Thompson AM, Cohen PA.

    Breast Cancer Res. 2008;10(5):R88. Epub 2008 Oct 17.

    PMID:
    18928543
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    5.

    Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy.

    Truong PT, Olivotto IA, Kader HA, Panades M, Speers CH, Berthelet E.

    Int J Radiat Oncol Biol Phys. 2005 Apr 1;61(5):1337-47.

    PMID:
    15817335
    [PubMed - indexed for MEDLINE]
    6.

    Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer.

    Touboul E, Buffat L, Belkacémi Y, Lefranc JP, Uzan S, Lhuillier P, Faivre C, Huart J, Lotz JP, Antoine M, Pène F, Blondon J, Izrael V, Laugier A, Schlienger M, Housset M.

    Int J Radiat Oncol Biol Phys. 1999 Jan 1;43(1):25-38.

    PMID:
    9989511
    [PubMed - indexed for MEDLINE]
    7.

    The role of aromatase and 17-beta-hydroxysteroid dehydrogenase type 1 mRNA expression in predicting the clinical outcome of human breast cancer.

    Salhab M, Reed MJ, Al Sarakbi W, Jiang WG, Mokbel K.

    Breast Cancer Res Treat. 2006 Sep;99(2):155-62. Epub 2006 Mar 16.

    PMID:
    16541304
    [PubMed - indexed for MEDLINE]
    9.

    Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.

    Lee KH, Im SA, Oh DY, Lee SH, Chie EK, Han W, Kim DW, Kim TY, Park IA, Noh DY, Heo DS, Ha SW, Bang YJ.

    BMC Cancer. 2007 Apr 12;7:63.

    PMID:
    17430582
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    10.

    Long-term follow-up of axillary node-positive breast cancer patients receiving adjuvant systemic therapy alone: patterns of recurrence.

    Fisher BJ, Perera FE, Cooke AL, Opeitum A, Venkatesan V, Dar AR, Stitt L.

    Int J Radiat Oncol Biol Phys. 1997 Jun 1;38(3):541-50.

    PMID:
    9231678
    [PubMed - indexed for MEDLINE]
    11.

    Triple-negative high-risk breast cancer derives particular benefit from dose intensification of adjuvant chemotherapy: results of WSG AM-01 trial.

    Gluz O, Nitz UA, Harbeck N, Ting E, Kates R, Herr A, Lindemann W, Jackisch C, Berdel WE, Kirchner H, Metzner B, Werner F, Schütt G, Frick M, Poremba C, Diallo-Danebrock R, Mohrmann S; West German Study Group.

    Ann Oncol. 2008 May;19(5):861-70. Epub 2008 Jan 3.

    PMID:
    18174609
    [PubMed - indexed for MEDLINE]
    Free Article
    12.

    Patients with t1 to t2 breast cancer with one to three positive nodes have higher local and regional recurrence risks compared with node-negative patients after breast-conserving surgery and whole-breast radiotherapy.

    Truong PT, Jones SO, Kader HA, Wai ES, Speers CH, Alexander AS, Olivotto IA.

    Int J Radiat Oncol Biol Phys. 2009 Feb 1;73(2):357-64.

    PMID:
    18676091
    [PubMed - indexed for MEDLINE]
    13.

    Changes in management techniques and patterns of disease recurrence over time in patients with breast carcinoma treated with breast-conserving therapy at a single institution.

    Pass H, Vicini FA, Kestin LL, Goldstein NS, Decker D, Pettinga J, Ingold J, Benitez P, Neumann K, Rebner M, Dekhne N, Martinez A.

    Cancer. 2004 Aug 15;101(4):713-20.

    PMID:
    15305400
    [PubMed - indexed for MEDLINE]
    Free Article
    14.

    [Local relapse in young (< or = 40 years) women with breast cancer after mastectomy or breast conserving surgery: 15-year results].

    Fodor J, Mózsa E, Zaka Z, Polgár C, Major T.

    Magy Onkol. 2005;49(3):203, 205-8. Epub 2005 Oct 25. Hungarian.

    PMID:
    16249814
    [PubMed - indexed for MEDLINE]
    Free Article
    15.

    Locoregional recurrence of breast cancer following mastectomy: always a fatal event? Results of univariate and multivariate analysis.

    Willner J, Kiricuta IC, Kölbl O.

    Int J Radiat Oncol Biol Phys. 1997 Mar 1;37(4):853-63.

    PMID:
    9128962
    [PubMed - indexed for MEDLINE]
    16.

    Expression of p53, glutathione S-transferase-pi, and Bcl-2 proteins and benefit from adjuvant radiotherapy in breast cancer.

    Silvestrini R, Veneroni S, Benini E, Daidone MG, Luisi A, Leutner M, Maucione A, Kenda R, Zucali R, Veronesi U.

    J Natl Cancer Inst. 1997 May 7;89(9):639-45.

    PMID:
    9150188
    [PubMed - indexed for MEDLINE]
    Free Article
    17.

    Influence of the time between surgery and radiotherapy on local recurrence in patients with lymph node-positive, early-stage, invasive breast carcinoma undergoing breast-conserving surgery: results of the French Adjuvant Study Group.

    Benchalal M, Le Prisé E, de Lafontan B, Berton-Rigaud D, Belkacemi Y, Romestaing P, Peignaux K, Courdi A, Monnier A, Montcuquet P, Goudier MJ, Marchal C, Chollet P, Abadie-Lacourtoisie S, Datchary J, Veyret C, Kerbrat P.

    Cancer. 2005 Jul 15;104(2):240-50.

    PMID:
    15948160
    [PubMed - indexed for MEDLINE]
    Free Article
    18.

    Carbonic anhydrase IX and response to postmastectomy radiotherapy in high-risk breast cancer: a subgroup analysis of the DBCG82 b and c trials.

    Kyndi M, Sørensen FB, Knudsen H, Alsner J, Overgaard M, Nielsen HM, Overgaard J; Danish Breast Cancer Cooperative Group.

    Breast Cancer Res. 2008;10(2):R24. Epub 2008 Mar 20.

    PMID:
    18355402
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    19.

    Enhanced prediction of breast cancer prognosis by evaluating expression of p53 and prostate-specific antigen in combination.

    Yu H, Levesque MA, Clark GM, Diamandis EP.

    Br J Cancer. 1999 Oct;81(3):490-5.

    PMID:
    10507775
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    20.

    Combined chemotherapy and preoperative irradiation for locally advanced noninflammatory breast cancer: updated results in a series of 120 patients.

    Lerouge D, Touboul E, Lefranc JP, Genestie C, Moureau-Zabotto L, Blondon J.

    Int J Radiat Oncol Biol Phys. 2004 Jul 15;59(4):1062-73.

    PMID:
    15234040
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Write to the Help Desk